f.demir
TL2 Regular · Izmir, TR
Interested in documentation quality as a proxy for process quality. A tidy COA is not proof, but a sloppy one is a signal.
Joined 3 July 2025 · last posted 6d · groups: translators
83 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #84 · Outcomes › Progress reports · 22 Jul 2026 · 19 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops. For what it is worth, the same…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #16 · Compounds › Oral incretins · 22 Jul 2026 · 0 likes PIONEER 6 cardiovascular safety is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth…
-
A structured critique template this community uses — a second dataset Replied, post #39 · Evidence › Study critique · 15 Jul 2026 · 0 likes Post #38 describes the usual case. This is about the unusual one. Offering a way to settle structured critique template rather than another opinion about it. Two…
-
How to ask a question when you cannot say why you are asking it Replied, post #34 · Start Here › How to Ask · 8 Jul 2026 · 5 likes Taking post #33 at face value and following it one step further. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
-
Packaging that arrived damaged: documenting it properly Replied, post #36 · Sourcing › Logistics · 4 Jul 2026 · 3 likes Coming back to post #34, because the follow-up matters more than the original answer. Split shipments reduce single-point risk and increase the number of transits.…
-
Insurance and replacement policies, compared Replied, post #60 · Sourcing › Logistics · 3 Jul 2026 · 4 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Pages past their review date, listed — does this still hold? Replied, post #22 · Meta › Wiki maintenance · 23 Jun 2026 · 21 likes One more thing on Pages past that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #38 · Compounds › Tirzepatide · 15 Jun 2026 · 3 likes Answering the question post #35 raises rather than the one it answers. On the mechanism question specifically: the honest position is that GIP agonism plausibly…
-
Revisiting: The best-written scientific paper you have read Replied, post #29 · Lounge › Off topic · 13 Jun 2026 · 15 likes Agreed on all of that, and I have nothing to add to it.
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #87 · Sourcing › Logistics · 31 May 2026 · 0 likes My understanding of Regional warehouse stock versus direct is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #24 · Outcomes › Body composition · 22 May 2026 · 5 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology.
-
Transporting a vial for a weekend away — a second dataset Replied, post #57 · Practice › Storage & stability · 19 May 2026 · 28 likes Sensible. I would want the same detail before I acted on it either.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #47 · Compounds › Semaglutide · 1 May 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
Research-use-only status: what it means legally and practically Replied, post #33 · Compounds › Other compounds · 26 Apr 2026 · 30 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #5 · Outcomes › Body composition · 23 Apr 2026 · 10 likes Percentage body fat is a ratio, so it changes when either component changes. A rising percentage during weight loss is arithmetic before it is physiology.
-
Spike-and-recover accuracy for a peptide assay Replied, post #33 · Analytics › Method validation · 8 Apr 2026 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. I would rather say I do not know…
-
A plateau that disappeared when I changed how I measured Replied, post #28 · Outcomes › Progress reports · 31 Mar 2026 · 6 likes Coming back to post #24, because the follow-up matters more than the original answer. Include what else changed. Training, illness, travel and a different scale all…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #40 · Lounge › Introductions · 11 Mar 2026 · 0 likes Introductions are also a reasonable place to say what you are hoping to find, because somebody will usually know whether it exists here already. The step people skip is…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #7 · Evidence › Preprints · 7 Mar 2026 · 10 likes Adding the measurement that post #4 says would settle it. Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #14 · Compounds › Repair & healing peptides · 25 Feb 2026 · 0 likes That is a cleaner way of putting what I was circling around.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #108 · Analytics › Mass spectrometry · 15 Feb 2026 · 0 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass. Take the reasoning…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #28 · Research Methods › N-of-1 designs · 4 Feb 2026 · 10 likes Saving this. It is the version I will quote when the question comes round again.
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #7 · Compounds › Repair & healing peptides · 3 Feb 2026 · 0 likes Right, and stated more narrowly than I would have dared to state it.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #104 · Clinical › Special populations · 26 Jan 2026 · 0 likes Where I part company with post #102, and it is a narrow parting. Distinguishing three things in the Pregnancy and pregnancy planning discussion that keep getting used…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #2 · Practice › Dosing & titration · 24 Jan 2026 · 5 likes Taking the opening post at face value and following it one step further. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the…
-
Waist circumference technique and its repeatability Replied, post #39 · Outcomes › Progress reports · 16 Jan 2026 · 5 likes For anyone finding this later: the short answer on waist circumference technique is that it depends on one thing, and the rest of the thread is people identifying which…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #22 · Compounds › Oral incretins · 10 Jan 2026 · 0 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
-
Aggregates and why a purity assay may miss them entirely Replied, post #60 · Analytics › Impurities & related substances · 9 Jan 2026 · 0 likes Answering the question post #56 raises rather than the one it answers. Comparing impurity profiles across suppliers is much more informative than comparing purity…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #27 · Sourcing › Red flags · 26 Dec 2025 · 24 likes Post #23 and I disagree about the size of the effect, not about the direction. What would change my mind on supplier is a second dataset collected by someone with no…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #56 · Sourcing › Regulatory · 29 Nov 2025 · 3 likes Adding the measurement that post #53 says would settle it. Pharmaceutical compounding rules was covered in the wiki last year and the page has a review date on it,…
-
Robustness: the parameters worth deliberately varying Replied, post #25 · Analytics › Method validation · 27 Nov 2025 · 6 likes Taking robustness seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those two…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #62 · Analytics › Home & field testing · 25 Nov 2025 · 11 likes Worth separating two things that post #58 runs together. An update on my earlier home kit substitute post: the pattern held for another six weeks and then stopped,…
-
Thyroid function tests during substantial weight change Replied, post #114 · Clinical › Bloodwork · 29 Oct 2025 · 3 likes Understood. Thank you for being specific about the limits of it.
-
What pooling buys you and what it destroys Replied, post #46 · Evidence › Meta-analyses · 19 Oct 2025 · 15 likes Taking post #45 at face value and following it one step further. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
-
Absence of evidence and evidence of absence Replied, post #2 · Research Methods › Statistics · 11 Oct 2025 · 11 likes This follows the opening post rather than contradicting it. Adding a null result on absence of evidence. I looked, carefully, and found nothing, and null results…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #99 · Compounds › Cagrilintide & amylin analogues · 5 Oct 2025 · 19 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Specification in the result column: why that is a meaningful error Replied, post #51 · Analytics › COA interpretation · 29 Sep 2025 · 9 likes Noted, and thank you for writing it out rather than summarising it.
-
Documentation that materially improves an appeal's chances Replied, post #9 · Access › Insurance & coverage · 24 Sep 2025 · 10 likes Worth separating two things that post #7 runs together. Keep every document with dates in one place. An appeal months later is assembled from whatever you kept. Reading…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #38 · Analytics › COA interpretation · 19 Sep 2025 · 11 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #44 · Practice › Storage & stability · 19 Sep 2025 · 1 like Post #43 is right about the mechanism and I think understates the practical bit. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
Which panel is worth repeating and which is worth ignoring Replied, post #105 · Clinical › Bloodwork · 7 Sep 2025 · 11 likes The arithmetic in post #102 is right; the assumption feeding it is the part to check. Add biological variation and analytical imprecision to that base rate and the…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #19 · Analytics › Method validation · 28 Aug 2025 · 2 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. The uncertainty is in the…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #17 · Practice › Side effects · 26 Aug 2025 · 0 likes Agreed on all of that, and I have nothing to add to it.
-
What this community means by "a source", in practical terms Replied, post #76 · Start Here › Welcome · 18 Aug 2025 · 16 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #6 · Data & Tools › Calculators · 17 Aug 2025 · 0 likes A tool that refuses to give an answer when the result falls below one graduation is doing something useful. Most just print the number.
-
Asking about a compound your prescriber has not heard of Replied, post #125 · Clinical › Prescriber conversations · 13 Aug 2025 · 24 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #48 · Practice › Dosing & titration · 9 Aug 2025 · 7 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #20 · Access › Pricing · 9 Aug 2025 · 21 likes Landed cost including shipping, fees and currency conversion is what you actually pay, and quotes that look identical frequently are not.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #96 · Practice › Reconstitution · 6 Jul 2025 · 0 likes Worth separating two things that post #92 runs together. The question underneath reconstituting a multi-strength kit is usually "how would I tell?" rather than "what is…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #18 · Compounds › Secretagogues & GH axis · 24 Jun 2025 · 33 likes A definition problem is doing most of the work in this reading a rodent study discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
A ten-fold dose error caught before injection Replied, post #52 · Devices › Syringes & needles · 20 Jun 2025 · 0 likes Silicone coating on the barrel affects how smoothly the plunger moves and how a very slow injection feels. It is one reason two syringes at the same specification are…
-
A comparison of home results against a laboratory result on the same vial Replied, post #6 · Analytics › Home & field testing · 17 Jun 2025 · 1 like That reframing is the whole thing. The facts I already had.
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #7 · Pharmacology › Receptor biology · 15 Jun 2025 · 2 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Coming back to: Getting a referral rather than a refusal Replied, post #46 · Clinical › Prescriber conversations · 8 Jun 2025 · 11 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
A well-designed study with a badly written abstract Replied, post #116 · Evidence › Study critique · 30 May 2025 · 24 likes The practical version of well-designed study is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #20 · Compounds › Cagrilintide & amylin analogues · 26 May 2025 · 4 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #88 · Outcomes › Body composition · 24 May 2025 · 0 likes Taking DXA precision seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #63 · Outcomes › Body composition · 19 May 2025 · 0 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Publishing an inconvenient result: a case study Replied, post #21 · Sourcing › Independent verification · 17 May 2025 · 6 likes Post #20 is right about the mechanism and I think understates the practical bit. Combining a chromatographic result with a documentation review gives a more complete…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #83 · Access › Pricing · 30 Apr 2025 · 10 likes Where I part company with post #79, and it is a narrow parting. Nothing here is financial advice and none of it is a route to a transaction.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #2 · Clinical › Special populations · 26 Apr 2025 · 11 likes My position on History of disordered eating is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Carryover and the ghost peak from last week's standard Replied, post #71 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 26 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Retatrutide dose escalation in the published trials Replied, post #87 · Compounds › Retatrutide · 4 Apr 2025 · 19 likes Post #84 answers the question as asked. The question underneath it is different. The failure mode on retatrutide dose escalation is boring rather than dramatic. It is…
-
Carryover and the ghost peak from last week's standard Replied, post #2 · Analytics › HPLC & UHPLC · 31 Mar 2025 · 24 likes Agreed on carryover, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #131 · Analytics › COA interpretation · 27 Mar 2025 · 14 likes Whatever the answer on Counter-ion form turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
When to suspect the method rather than the sample Replied, post #92 · Analytics › Method validation · 5 Mar 2025 · 0 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #13 · Practice › Reconstitution · 7 Feb 2025 · 5 likes Coming back to post #9, because the follow-up matters more than the original answer. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #59 · Compounds › Secretagogues & GH axis · 30 Jan 2025 · 10 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
Protein density versus volume when you cannot eat much Replied, post #37 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 14 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help. Anyone…
-
Coming back to: Cost per delivered dose, which is the number that matters Replied, post #10 · Access › Pricing · 3 Jan 2025 · 6 likes Worth separating two things that post #8 runs together. A pen and a vial are not the same product. Dead volume, wastage and the number of doses actually obtainable all…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #11 · Compounds › Oral incretins · 1 Jan 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #81 · Access › Insurance & coverage · 22 Dec 2024 · 1 like Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by manufacturers can reduce costs. Eligibility requirements exist…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #27 · Compounds › Semaglutide · 20 Dec 2024 · 1 like The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #55 · Nutrition & Training › Protein & intake · 13 Dec 2024 · 13 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #21 · Compounds › Cagrilintide & amylin analogues · 11 Nov 2024 · 9 likes Coming back to post #20, because the follow-up matters more than the original answer. Practical note on amylin analogue mechanism: write down what you expect before you…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #45 · Clinical › Prescriber conversations · 9 Nov 2024 · 25 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Time to steady state after a dose increase Replied, post #150 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #106 · Analytics › COA interpretation · 4 Nov 2024 · 8 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Time to steady state after a dose increase Replied, post #64 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 0 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #5 · Practice › Interactions · 21 Oct 2024 · 10 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #9 · Clinical › Comorbidities · 9 Oct 2024 · 15 likes Taking post #8 at face value and following it one step further. Eating-disorder history is raised here regularly and is the case where the guidance most consistently…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #21 · Sourcing › Independent verification · 28 Aug 2024 · 5 likes Splitting a vial is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Promotion criteria, and the one that stops most nominations Replied, post #41 · Documentation › Doc review · 18 Aug 2024 · 0 likes The documentation on promotion criteria is better than this thread and I say that as someone who has posted in the thread.